It can take up to six years to build up a body of evidence to support a new drug candidate for commercial development. That’s a long time. At twoXAR, we are turning those years into minutes. Whether we are using your data to generate new drug candidates for a specific disease or assessing the efficacy of existing therapeutics, we can help. Using big data and patent-pending algorithms, we radically reduce the time it takes to find new drug candidates and assess their efficacy. Using our DUMA™ Drug Discovery platform we evaluate large public and proprietary datasets to identify and rank high probability drug-disease matches orders of magnitude faster than wet-lab approaches. These matches can be used to cross-validate clinical research, repurpose existing medicines, or identify novel drug candidates for further clinical testing.
Palo Alto, US
12 (est)
twoXAR was founded in 2014 and is headquartered in Palo Alto, US

twoXAR Locations

Palo Alto, US

twoXAR Metrics

twoXAR Summary

Founding Date


Total Funding

$3.4 M

Latest funding size

$3.4 M

Time since last funding

about 1 year


twoXAR's latest funding round of $3.4 M was in November 2015. In total, twoXAR has raised $3.4 M.

twoXAR Company Life